Headlines
- Construction proceeding on schedule at G2_Austin, timeline for completion unchanged. Construction on the first 2.1 GW phase of T1’s flagship
U.S. solar cell fab, G2_Austin, is progressing according to plan. During the first quarter, long lead time capital items including the steel package were ordered while ground works and infrastructure development at the site advanced. Concrete works commenced inApril 2026 , and the engineering team completed design work by finalizing the full Issued for Construction package in early May. T1 expects to begin erecting the first structural steel at G2 later in May, and the Company continues to target initial cell production at G2 in Q4 2026. - T1 achieves record quarterly Net Income from Continuing Operations of
$3.9 million and record quarterly Adjusted EBITDA of$9.1 million in Q1 2026. Following the successful ramp of production at G1_Dallas in 2025, T1 achieved record quarterly profitability during the first quarter of 2026 due to higher than forecasted G1_Dallas production and sales, along with a favorable sequential mix shift of deliveries from merchant sales to fixed margin and cost-plus offtake contracts, and lower third-party fees. - Capital formation is progressing through diligence. T1 has identified and is targeting a comprehensive financing solution in Q2 2026 that includes a significant debt component to fund the remaining estimated capital spending required for the 2.1 GW Phase 1 of G2_Austin. With
$174.7 million of estimated net proceeds generated from the pricing of the Company’s upsized public offering of convertible senior notes inApril 2026 , the estimated Phase 1 financing requirement now stands at approximately$225 million .
“Our team made excellent progress during the first quarter to advance our top priorities: operate profitably at G1_Dallas, fund and build G2_Austin, and establish T1 as an integrated, homegrown
Business update and guidance
- Maintaining 2026 operating guidance and awaiting clarity on key swing factors for 2026 financial guidance. T1’s 2026 production guidance range of 3.1 – 4.2 GW from G1_Dallas is unchanged. The Company believes it is well positioned to achieve the high-end of this targeted production range in 2026 based on continued progress qualifying international cell vendors. Other swing factors that could impact T1’s 2026 Adjusted EBITDA include: customer merchant sales demand for H2 2026, a potential ruling in the
U.S. Department of Commerce’s Section 232 investigation into foreign sourced polysilicon and derivatives, and the status of International Emergency Economic Powers Act (“IEEPA”) tariffs. - Preliminary indications of incremental customer demand for integrated G1_Dallas/G2_Austin high domestic content modules. T1 continues to pursue multi-year offtake contracts through strategic partnerships as well as merchant sales opportunities. With safe harboring deadlines and a potential Section 232 outcome looming, Indicative customer demand for potential G1/G2 offtakes covers more than 100% of the Company’s anticipated G1/G2 production capacity for 2027 - 2028.
- T1 is committed to strategic alignment with key
U.S. policy initiatives. As a large buyer ofU.S. polysilicon and wafers through long-term supply agreements withHemlock Semiconductor and Corning Inc. (NYSE: GLW), T1 believes it is well positioned for a potential ruling in theU.S. Department of Commerce’s Section 232 investigation into foreign sourced polysilicon. - T1 underscores commitment to American advanced manufacturing with organizational development. The Company continues to strengthen and grow key functions in sales, engineering, and supply chain to expand T1’s commercial presence in the utility-scale and hyperscaler ecosystems, enhance internal technical capabilities, and build cost optimized, integrated
U.S. and global supply chains.
Subsequent Events to Q1 2026
- T1 completed an upsized public offering of convertible senior notes due 2031. In
April 2026 , the Company completed a public offering of$160 million aggregate principal amount of its 4.00% convertible senior notes due 2031. The offering, which was upsized from an originally targeted$125.0 million , generated net proceeds of$174.7 million and has positioned T1 to progress construction of the 2.1 GW Phase 1 of G2_Austin while the company pursues a comprehensive financing solution with a significant debt component.
Q1 2026 Results Overview
T1 Energy reported a net loss attributable to common stockholders for the first quarter of 2026 of$21.4 million , or$(0.08) per share compared to a net loss of$17.1 million , or$(0.11) per share for the first quarter of 2025. Net income from continuing operations was$3.9 million , or$0.01 per share for the first quarter of 2026 compared to a net loss from continuing operations of$6.3 million , or$(0.05) per share for the first quarter of 2025. Net loss from discontinued operations was$24.3 million , or$(0.09) per share for the first quarter of 2026 compared to$10.0 million , or$(0.06) per share for the first quarter of 2025.- As of
March 31, 2026 , T1 had cash, cash equivalents, and restricted cash of$123.7 million , of which$46.4 million was unrestricted cash.
Presentation of First Quarter 2026 Results
A presentation will be held today,
Participants can access the conference call by clicking the following link and completing the online registration form. Upon registering participants will receive the dial-in info and PIN to join the call.
The call will also be available by clicking the webcast link.
About
To learn more about T1, please visit www.T1energy.com and follow on social media.
Investor contact:
EVP, Investor Relations and Corporate Development
jeffrey.spittel@T1energy.com
Tel: +1 409 599-5706
Media contact:
EVP,
russell.gold@T1energy.com
Tel: +1 214 616-9715
Cautionary Statement Concerning Forward-Looking Statements:
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation with respect to T1’s strategy of developing as an integrated
T1 intends to use its website as a channel of distribution to disclose information which may be of interest or material to investors and to communicate with investors and the public. Such disclosures will be included on T1’s website in the ‘Investor Relations’ section. T1, and its CEO and Chairman of the Board,
Use of Non-GAAP Financial Measures
T1 reports financial results in accordance with generally accepted accounting principles in
T1 defines Adjusted EBITDA as net income (loss) from continuing operations before interest expense, income tax expense (benefit), depreciation and amortization, and further adjustments to exclude certain items that management does not consider indicative of the Company’s core operating performance, including, but not limited to, non-cash charges, non-recurring items, and non-operating gains or losses. These adjustments include impairment charges, losses on debt extinguishment, losses on settlement of derivative liabilities, share-based compensation, fair value adjustments of warrant and derivative liabilities, and non-recurring transaction expenses. Our Adjusted EBITDA measure was re-defined in the fourth quarter of 2025 to also exclude certain non-recurring transaction expenses. The historical presentation of Adjusted EBITDA in this press release has been recast to conform to the revised definition.
T1 uses Adjusted EBITDA as a key measure in evaluating its financial and operating performance and in making strategic business decisions. T1 believes that Adjusted EBITDA, when considered together with the corresponding GAAP financial measures, provides meaningful supplemental information by excluding items that may not be representative of its core business, operating results, or future outlook. However, Adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered as an alternative to net income (loss) from continuing operations or any other measure of performance or liquidity presented in accordance with GAAP.
Adjusted EBITDA has been reconciled to the nearest GAAP measure for historical periods in the table entitled “Reconciliation of Non-GAAP Measures to Most Comparable Amounts” set forth on Annex A of this press release.
CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except per share data) (Unaudited) | ||||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 46,367 | $ | 182,450 | ||||
| Restricted cash | 70,178 | 81,203 | ||||||
| Accounts receivable trade, net - related parties | 100,023 | 84,481 | ||||||
| Government grants receivable, net | 77,801 | 36,376 | ||||||
| Inventory | 128,941 | 116,043 | ||||||
| Advances to suppliers | 139,105 | 137,532 | ||||||
| Other current assets | 10,466 | 5,989 | ||||||
| Current assets of discontinued operations | 11,791 | 19,418 | ||||||
| Total current assets | 584,672 | 663,492 | ||||||
| Restricted cash | 7,120 | 7,120 | ||||||
| Property and equipment, net | 345,956 | 302,302 | ||||||
| 57,449 | 57,449 | |||||||
| Intangible assets, net | 169,131 | 180,481 | ||||||
| Right-of-use asset under operating leases | 162,834 | 151,166 | ||||||
| Other assets | 9,916 | 10,098 | ||||||
| Total assets | $ | 1,337,078 | $ | 1,372,108 | ||||
| LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 96,493 | $ | 91,323 | ||||
| Accrued liabilities and other | 64,661 | 47,224 | ||||||
| Deferred revenue | 90,006 | 56,731 | ||||||
| Derivative liabilities | 1,132 | 11,661 | ||||||
| Current portion of long-term debt | 48,236 | 46,357 | ||||||
| Accounts payable and accrued liabilities - related parties | 108,964 | 162,754 | ||||||
| Current liabilities of discontinued operations | 56,397 | 47,538 | ||||||
| Total current liabilities | 465,889 | 463,588 | ||||||
| Long-term deferred revenue | 48,189 | 48,189 | ||||||
| Convertible notes | 153,381 | 152,960 | ||||||
| Operating lease liability | 154,069 | 143,534 | ||||||
| Long-term debt | 122,604 | 137,303 | ||||||
| Long-term debt - related party | 54,185 | 53,538 | ||||||
| Deferred tax liability | 3,222 | 3,758 | ||||||
| Other long-term liabilities | 26,332 | 47,353 | ||||||
| Total liabilities | 1,027,871 | 1,050,223 | ||||||
| Commitments and contingencies | ||||||||
| Redeemable preferred stock | ||||||||
| Series B convertible non-voting preferred stock, outstanding as of both accrued dividends of | 18,045 | 17,805 | ||||||
| Series B-1 convertible non-voting preferred stock, outstanding as of both accrued dividends of | 54,460 | 53,710 | ||||||
| Equity: | ||||||||
| Common stock, | 2,790 | 2,663 | ||||||
| Additional paid-in capital | 1,358,278 | 1,358,992 | ||||||
| Accumulated other comprehensive loss | (10,875 | ) | (18,213 | ) | ||||
| Accumulated deficit | (1,113,491 | ) | (1,093,072 | ) | ||||
| Total equity | 236,702 | 250,370 | ||||||
| Total liabilities, redeemable preferred stock and equity | $ | 1,337,078 | $ | 1,372,108 | ||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (In thousands, except per share data) (Unaudited) | |||||||
| Three months ended | |||||||
| 2026 | 2025 | ||||||
| Net sales | $ | 241 | $ | — | |||
| Net sales - related party | 177,406 | 53,452 | |||||
| Total net sales | 177,647 | 53,452 | |||||
| Cost of sales | 148,563 | 35,671 | |||||
| Gross profit | 29,084 | 17,781 | |||||
| Operating expenses: | |||||||
| Selling, general and administrative | 51,589 | 43,379 | |||||
| Total operating expenses | 51,589 | 43,379 | |||||
| Operating loss from continuing operations | (22,505 | ) | (25,598 | ) | |||
| Other (expense) income: | |||||||
| Warrant liability fair value adjustment | 10,413 | 1,567 | |||||
| Derivative liabilities fair value adjustment | 19,955 | 25,229 | |||||
| Impairment of assets previously classified as held for sale | — | (282 | ) | ||||
| Interest expense, net | (6,164 | ) | (9,853 | ) | |||
| Other income, net | 1,981 | 163 | |||||
| Total other income | 26,185 | 16,824 | |||||
| Income (loss) from continuing operations before income taxes | 3,680 | (8,774 | ) | ||||
| Income tax benefit | 222 | 2,513 | |||||
| Net income (loss) from continuing operations | 3,902 | (6,261 | ) | ||||
| Net loss from discontinued operations, net of tax | (24,321 | ) | (9,978 | ) | |||
| Net loss | (20,419 | ) | (16,239 | ) | |||
| Preferred dividends and accretion | (990 | ) | (891 | ) | |||
| Net loss attributable to common stockholders | $ | (21,409 | ) | $ | (17,130 | ) | |
| Weighted average shares outstanding: | |||||||
| Weighted average shares of common stock outstanding - basic | 278,539 | 155,933 | |||||
| Weighted average shares of common stock outstanding - diluted | 285,252 | 155,933 | |||||
| Net income (loss) per share attributable to common stockholders: | |||||||
| Net income (loss) per share from continuing operations - basic and diluted | $ | 0.01 | $ | (0.05 | ) | ||
| Net loss per share from discontinued operations - basic and diluted | $ | (0.09 | ) | $ | (0.06 | ) | |
| Net loss per share - basic and diluted | $ | (0.08 | ) | $ | (0.11 | ) | |
| Other comprehensive income (loss): | |||||||
| Net loss | $ | (20,419 | ) | $ | (16,239 | ) | |
| Foreign currency translation adjustments | 7,338 | 26,065 | |||||
| Total comprehensive income (loss) | (13,081 | ) | 9,826 | ||||
| Preferred dividends and accretion | (990 | ) | (891 | ) | |||
| Comprehensive income (loss) attributable to common stockholders | $ | (14,071 | ) | $ | 8,935 | ||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) (Unaudited) | ||||||||
| Three months ended | ||||||||
| 2026 | 2025 | |||||||
| Cash flows from operating activities: | ||||||||
| Net loss | $ | (20,419 | ) | $ | (16,239 | ) | ||
| Adjustments to reconcile net loss to cash used in operating activities: | ||||||||
| Share-based compensation expense | 2,738 | 3,939 | ||||||
| Depreciation and amortization | 25,105 | 14,678 | ||||||
| Impairment of assets previously classified as held for sale | — | 282 | ||||||
| Change in valuation allowance | 15,358 | (645 | ) | |||||
| Change in fair value of derivative liabilities | (19,955 | ) | (25,229 | ) | ||||
| Gain on sale of property and equipment | — | (5,675 | ) | |||||
| Amortization of debt issuance costs, premium and discount | 1,873 | 4,640 | ||||||
| Reduction in the carrying amount of right-of-use assets | 2,095 | 1,689 | ||||||
| Warrant liability fair value adjustment | (10,413 | ) | (1,567 | ) | ||||
| Deferred income taxes | (536 | ) | (995 | ) | ||||
| Other | (20 | ) | 2,350 | |||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable trade, net - related parties | (15,542 | ) | (18,005 | ) | ||||
| Government grants receivable, net | (41,425 | ) | (13,393 | ) | ||||
| Inventory | (12,898 | ) | (58,483 | ) | ||||
| Other assets | 183 | — | ||||||
| Advances to suppliers and other current assets | (10,027 | ) | (358 | ) | ||||
| Accounts payable, accrued liabilities and other | (22,266 | ) | 56,827 | |||||
| Deferred revenue | 33,275 | 11,370 | ||||||
| Net cash used in operating activities | (72,874 | ) | (44,814 | ) | ||||
| Cash flows from investing activities: | ||||||||
| Proceeds from the return of property and equipment deposits | — | 1,202 | ||||||
| Purchases of property and equipment | (60,724 | ) | (29,141 | ) | ||||
| Proceeds from the sale of property and equipment | — | 50,000 | ||||||
| Net cash (used in) provided by investing activities | (60,724 | ) | 22,061 | |||||
| Cash flows from financing activities: | ||||||||
| Repayment of Senior Secured Credit Facility | (13,625 | ) | — | |||||
| Exercise of Penny Warrants | 70 | — | ||||||
| Payment of debt issuance costs | — | (3,760 | ) | |||||
| Net cash used in financing activities | (13,555 | ) | (3,760 | ) | ||||
| Effect of changes in foreign exchange rates on cash, cash equivalents, and restricted cash | 45 | 959 | ||||||
| Net decrease in cash, cash equivalents, and restricted cash | (147,108 | ) | (25,554 | ) | ||||
| Cash, cash equivalents, and restricted cash at beginning of period | 270,773 | 76,645 | ||||||
| Cash, cash equivalents, and restricted cash at end of period | $ | 123,665 | $ | 51,091 | ||||
| Reconciliation to condensed consolidated balance sheets: | ||||||||
| Cash and cash equivalents | $ | 46,367 | $ | 48,881 | ||||
| Restricted cash | 77,298 | 2,210 | ||||||
| Cash, cash equivalents, and restricted cash | $ | 123,665 | $ | 51,091 | ||||
RECONCILIATION OF NON-GAAP MEASURES TO MOST COMPARABLE AMOUNTS (In thousands) (Unaudited) | ||||||||
| Three months ended | ||||||||
| 2026 | 2025 | |||||||
| Net loss | $ | (20,419 | ) | $ | (16,239 | ) | ||
| Net loss from discontinued operations, net of tax | 24,321 | 9,978 | ||||||
| Net income (loss) from continuing operations | 3,902 | (6,261 | ) | |||||
| Adjustments to net income (loss) from continuing operations | ||||||||
| Interest expense, net | 6,164 | 9,853 | ||||||
| Income tax benefit | (222 | ) | (2,513 | ) | ||||
| Depreciation and amortization | 25,105 | 14,678 | ||||||
| Impairment of assets previously classified as held for sale | — | 282 | ||||||
| Warrant liability fair value adjustment | (10,413 | ) | (1,567 | ) | ||||
| Derivative liabilities fair value adjustment | (19,955 | ) | (25,229 | ) | ||||
| Other income, net | (1,981 | ) | (163 | ) | ||||
| Share-based compensation expense | 2,738 | 3,939 | ||||||
| Transaction and nonrecurring expenses (1) | 3,796 | 2,980 | ||||||
| Adjusted EBITDA | $ | 9,134 | $ | (4,001 | ) | |||
| (1) | Transaction and nonrecurring expenses of |
Source: 